 Cardiovascular Diseases
"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 1 | 1 | 2 | | 1988 | 0 | 2 | 2 | | 1989 | 0 | 2 | 2 | | 1990 | 1 | 2 | 3 | | 1991 | 2 | 1 | 3 | | 1993 | 0 | 1 | 1 | | 1994 | 1 | 1 | 2 | | 1995 | 0 | 2 | 2 | | 1996 | 1 | 1 | 2 | | 1997 | 2 | 2 | 4 | | 1998 | 2 | 3 | 5 | | 1999 | 0 | 7 | 7 | | 2000 | 5 | 3 | 8 | | 2001 | 5 | 5 | 10 | | 2002 | 9 | 6 | 15 | | 2003 | 13 | 8 | 21 | | 2004 | 15 | 7 | 22 | | 2005 | 19 | 7 | 26 | | 2006 | 12 | 11 | 23 | | 2007 | 16 | 12 | 28 | | 2008 | 19 | 11 | 30 | | 2009 | 24 | 10 | 34 | | 2010 | 27 | 17 | 44 | | 2011 | 30 | 11 | 41 | | 2012 | 25 | 9 | 34 | | 2013 | 28 | 12 | 40 | | 2014 | 36 | 7 | 43 | | 2015 | 23 | 7 | 30 | | 2016 | 28 | 6 | 34 | | 2017 | 23 | 5 | 28 | | 2018 | 28 | 9 | 37 | | 2019 | 26 | 5 | 31 | | 2020 | 32 | 7 | 39 | | 2021 | 31 | 8 | 39 | | 2022 | 12 | 0 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Ruilope LM, Boletis J, Toto R, Umpierrez GE, Wanner C, Wada T, Scott C, Joseph A, Ogbaa I, Roberts L, Scheerer MF, Bakris GL. Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrol Dial Transplant. 2022 Jun 23; 37(7):1261-1269.
-
Shin S, Lee JE, Loftfield E, Shu XO, Abe SK, Rahman MS, Saito E, Islam MR, Tsugane S, Sawada N, Tsuji I, Kanemura S, Sugawara Y, Tomata Y, Sadakane A, Ozasa K, Oze I, Ito H, Shin MH, Ahn YO, Park SK, Shin A, Xiang YB, Cai H, Koh WP, Yuan JM, Yoo KY, Chia KS, Boffetta P, Ahsan H, Zheng W, Inoue M, Kang D, Potter JD, Matsuo K, Qiao YL, Rothman N, Sinha R. Coffee and tea consumption and mortality from all causes, cardiovascular disease and cancer: a pooled analysis of prospective studies from the Asia Cohort Consortium. Int J Epidemiol. 2022 05 09; 51(2):626-640.
-
Turner TA, Stein EA. Targeting PCSK9 inhibitors to those who will benefit most. Lancet Diabetes Endocrinol. 2022 05; 10(5):301-303.
-
Khomtchouk BB, Lee YS, Khan ML, Sun P, Mero D, Davidson MH. Targeting the cytoskeleton and extracellular matrix in cardiovascular disease drug discovery. Expert Opin Drug Discov. 2022 05; 17(5):443-460.
-
Turkson-Ocran RA, Foti K, Hines AL, Kamin Mukaz D, Kim H, Martin S, Minhas A, Norby FL, Ogungbe O, Razavi AC, Rooney MR, Sattler ELP, Scott J, Thomas AG, Tilves C, Wallace AS, Wang FM, Zhang M, Lutsey PL, Lancaster KJ. American Heart Association EPI|Lifestyle Scientific Sessions: 2021 Meeting Highlights. J Am Heart Assoc. 2022 03; 11(5):e024765.
-
Chang TE, Goldstein LB, Leifheit EC, Howard VJ, Lichtman JH. Cardiovascular Risk Factor Profiles, Emergency Department Visits, and Hospitalizations for Women and Men with a History of Stroke or Transient Ischemic Attack: A Cross-Sectional Study. J Womens Health (Larchmt). 2022 Jun; 31(6):834-841.
-
Agarwal R, Filippatos G, Pitt B, Anker SD, Rossing P, Joseph A, Kolkhof P, Nowack C, Gebel M, Ruilope LM, Bakris GL. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022 Feb 10; 43(6):474-484.
-
Yu D, Liao JK. Emerging views of statin pleiotropy and cholesterol lowering. Cardiovasc Res. 2022 01 29; 118(2):413-423.
-
McNavish DE, German CA, Shapiro MD. Should a Statin be Given to All Hypertensive Patients? Curr Hypertens Rep. 2022 01; 24(1):21-27.
-
Freedman AA, Papachristos AV, Smart BP, Keenan-Devlin LS, Khan SS, Borders A, Kershaw KN, Miller GE. Complaints about excessive use of police force in women's neighborhoods and subsequent perinatal and cardiovascular health. Sci Adv. 2022 01 21; 8(3):eabl5417.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|